|
Powered by Cell Signaling Technology |
Site Information |
---|
IEDGIIytQDFTVPG SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 448151 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on LKB1: | |
Effects of modification on biological processes: |
References | |
---|---|
Richer AL, et al. (2017) WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer. Cancer Res 77, 4663-4672
28652249 Curated Info |
|
Esteve-Puig R, et al. (2014) A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21WAF1/CIP1) Degradation. PLoS Genet 10, e1004721
25329316 Curated Info |
|
Shelly M, et al. (2007) LKB1/STRAD promotes axon initiation during neuronal polarization. Cell 129, 565-77
17482549 Curated Info |
|
Sapkota GP, et al. (2002) Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem J 368, 507-16
12234250 Curated Info |
|
Sapkota GP, et al. (2002) Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem J 362, 481-90
11853558 Curated Info |